Genetic Diseases, Inborn  >>  cyclosporine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
CYCLATOP, NCT02865356 / 2016-000467-16: Topical Solution for the Treatment of Atopic Dermatitis

Completed
2
36
Europe
Cyclosporine 5% solution, ciclosporin, Placebo, SP14019-F-02 Placebo
Spherium Biomed, Germans Trias i Pujol Hospital, Hospital del Mar, Hospital Sant Joan de Deu, Hospital Universitario Virgen Macarena, Hospital Universitario La Fe, Hospital General Universitario de Alicante, Fundación de Investigación Biomédica - Hospital Universitario de La Princesa, Hospital Universitario Virgen de la Victoria, Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Atopic Dermatitis
04/17
04/17
NCT02904772: Alipogene Tiparvovec for the Treatment of LPLD Patients

Withdrawn
2
0
US, Canada
alipogene tiparvovec, Glybera, Prednisolone, Cyclosporins, Mycophenolate mofetil
UniQure Biopharma B.V., Chiesi Farmaceutici S.p.A.
LPL Deficiency
06/20
09/20

Download Options